Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Gabrail Cancer Center, Canton, Ohio Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio